CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the publication of two studies and the presentation of two abstracts that further support the broader use of the CardioNet System for the detection of atrial fibrillation (AF). The studies demonstrate the CardioNet System’s ability to detect clinically significant AF events in patients following ischemic stroke or surgical AF ablation procedures.
